Purpose: Nonoperative treatment of recent internal carotid artery (ICA) occlusion is associated with increased recurrent stroke rates. We analyzed our results of carotid endarterectomy (CEA) for treatment of symptomatic recent ICA occlusion to evaluate its feasibility, safety, and outcomes. Methods: From 1990 to 2002, all patients with transient ischemic attack (TIA), amaurosis fugax, and minor stroke underwent duplex ultrasound (US) scanning and arteriography to confirm the diagnosis of ICA occlusion. Within 2 weeks of symptom onset, patients underwent operative exploration with attempted CEA. ICA occlusion was detected at preoperative angiography and confirmed at surgery. Patients with extensive ICA plaque not amenable to endarterectomy underwent external CEA with ICA ligation. Results: Over 12 years, 87 patients with symptomatic ICA occlusion underwent 90 operations for ICA exploration. In 30 patients (18 men, 12 women) with TIA (45%), amaurosis fugax (19%), or minor stroke (36%), CEA to treat ICA occlusion was technically successful. There was 1 postoperative stroke, 2 asymptomatic internal carotid occlusions, and no restenoses (mean follow-up, 26 months; range, 1-93 months). In 57 patients (37 men, 20 women) with TIA (41%), amaurosis fugax (27%), or stroke (32%) in whom CEA was unsuccessful, external CEA was performed. In this group there were no postoperative strokes, 2 asymptomatic external carotid artery occlusions, and 1 restenosis (>70%) (mean follow-up, 22 months; range, 1-73 months). There were no late strokes in either group. Conclusion: Operative exploration and endarterectomy to treat symptomatic ICA occlusion is feasible and safe. Patients with symptomatic ICA occlusion should be considered candidates for CEA. (J Vasc Surg 2003;37:785-8.)
Several randomized trials have validated the use of carotid endarterectomy (CEA) to treat symptomatic and asymptomatic hemodynamic significant carotid stenosis. 1, 2 However, treatment of symptomatic internal carotid artery (ICA) occlusion remains controversial. Despite optimal medical management, ICA occlusion is associated with increased ipsilateral recurrent stroke rates of 6% to 20% per year. [4] [5] [6] [7] [8] Furthermore, in the presence of substantial contralateral carotid artery stenosis, ICA occlusion doubles the risk for subsequent contralateral stroke. 9 Although earlier reports of carotid revascularization to treat ICA occlusion indicated dismal improvement in neurologic function, 10, 11 Kasper et al 12 have recently published their experience with beneficial effects of CEA in patients with ICA occlusion. To evaluate the feasibility and outcomes of CEA for treatment of acute and subacute symptomatic ICA occlusion, we analyzed our 12-year experience.
METHODS
We reviewed data for all patients undergoing surgical treatment of acute and subacute (within 14 days of symptom onset) symptomatic ICA occlusion between 1990 and 2002 from a prospectively collected vascular surgery registry. Preoperative diagnosis of ICA occlusion was confirmed with color-flow duplex US and arteriography (conventional digital subtraction or magnetic resonance). Patients were evaluated preoperatively by a consultant neurologist and the vascular surgery service. All patients with ICA occlusion had symptoms referable to the ipsilateral cerebral hemisphere and underwent surgical carotid revascularization within 14 days of symptom onset. Patient exclusion criteria included ICA occlusion after CEA, trauma, and severe neurologic deficit and obtundation (modified Rankin score Ն4). 13 Patients with ICA occlusion who had a patent ICA at the time of operative exploration were also excluded from the study.
Preoperative evaluation included computed tomography (CT) or magnetic resonance imaging (MRI) to evaluate the presence and severity of stroke. Regional cervical block (superficial and deep) was the preferred anesthetic, and general anesthesia with endotracheal intubation was selectively used in patients who did not tolerate cervical block. Carotid shunting was primarily used when neurologic deterioration occurred after placement of clamps, and was left to the discretion of the vascular surgeon. In all patients, ICA occlusion was confirmed at surgical exploration, and CEA was attempted with either eversion or the standard longitudinal technique. These techniques have been previously described. 3, 14 All patients received systemic heparin during surgery (intravenous heparin, 30 U/kg). After CEA, when thrombus was present in the distal ICA, it was gently grasped and extracted with forceps. When ICA backbleeding was not observed, a No. 2 Fogarty embolectomy catheter was carefully used for sequential ICA thrombectomy by advancing the catheter in 2 cm increments to a maximum of 10 cm. Patients with extensive ICA plaque not amenable to endarterectomy underwent external CEA with eversion or standard longitudinal techniques and ligation of the ICA. In patients with concomi-tant severe stenosis or occlusion of the proximal ipsilateral common carotid artery, adjunctive bypass from contralateral carotid, subclavian, or axillary arteries was performed to restore flow to the ipsilateral carotid bifurcation.
Postoperatively all patients remained in the post-anesthesia care unit for at least 4 to 6 hours, and their vital signs were monitored continuously. When hemodynamic parameters were stable, patients were transferred to the surgical floor. If hemodynamic or neurologic status was questionable, patients were transferred to a monitored bed in the intensive care unit. Any change in neurologic status was reevaluated with carotid duplex ultrasound scanning, head CT, or MRI. Postoperatively, all patients were given aspirin therapy at a dose of 81 mg/d. Routine postoperative surveillance included duplex US scanning at 1 and 6 months and yearly thereafter.
Based on a prospectively compiled vascular surgery registry, patients with symptomatic ICA occlusion were divided into two groups. Group 1 included patients who underwent internal and external CEA, and group II included patients not amenable to internal CEA who underwent external CEA only. All statistical tests were two-tailed, and P Ͻ .05 was considered to represent statistical significance.
RESULTS
Over 12 years, 90 carotid artery exploratory operations were performed at our institution in patients with acute and subacute symptomatic ICA occlusion. Three patients had symptoms referable to bilateral ICA occlusion. Of these, 31 (34%) patients underwent internal and external CEA (group 1) and 59 (66%) underwent external CEA only (group 2). One patient had common carotid artery occlusion and was excluded. Demographics, preoperative symptoms, and comorbid conditions for groups 1 and 2 are detailed in Table I . In groups 1 and 2, patients had symptoms of transient cerebral ischemic attack (TIA) (group 1, 45%; group 2, 41%), amaurosis fugax (group 1, 19%; group 2, 27%), and stroke (group 1, 36%; group 2, 32%). Comorbid conditions were similar except that substantially more patients in group 2 had a history of diabetes mellitus and cigarette smoking. Eighty-seven percent of group 1 patients and 94% of group 2 patients underwent carotid revascularization under cervical block; the remainder required general anesthesia. Carotid shunting was used in group 1 patients (n ϭ 2, 6%). Eversion CEA was performed in 21 patients (68%) in group 1 and 43 patients (73%) in group 2. Standard longitudinal CEA was performed in 10 patients (32%) in group 1 and 16 patients (22%) in group 2 (Table II) . Concomitant adjunctive procedures to improve inflow included carotid-carotid bypass (group 1, 3%; group 2, 3%), subclavian-carotid bypass (group 1, 7%; group 2, 2%), and axillary-carotid bypass (group 1, 3%; group 2, 0%) (Table III) .
Postoperative complications included neck hematoma (group 1, 7%; group 2, 2%), TIA (group 1, 3%; group 2, 0%), stroke (group 1, 3%; group 2, 0%), and myocardial infarction (group 1, 3%; group 2, 2%). The only stroke in (Table IV) . In patients with stroke there was improvement in 64% (7 of 11) in group 1 and none in group 2. Mean (ϮSE) hospital stay for group 1 was 7.25 Ϯ 0.29 days (range, 2-42 days) in group 1 and 4.82 Ϯ 0.10 days (range, 1-25 days) in group 2.
No patients in group 1 and 1 patient in group 2 died in the perioperative period (30 days). Two patients (7%) in group 1 and 6 patients (11%) in group 2 died of causes unrelated to carotid revascularization over a mean of 24 months (range, 2-51 months) (Table IV) . Causes of death were myocardial infarction (n ϭ 2) in group 1, and myocardial infarction (n ϭ 4), respiratory failure (n ϭ 1), and colon cancer (n ϭ 1) in group 2. Life table actuarial analysis indicated stroke-free survival of 91% at 1 and 3 years and 71% at 5 years in group 1, and 92% at 1 year, 86% at 3 years, and 60% at 5 years in group 2 (Tables V and VI) .
DISCUSSION
Since earlier results of carotid revascularization in the setting of acute and subacute occlusion were associated with dismal outcomes, currently accepted treatment options for symptomatic ICA occlusion are geared toward optimizing medical therapy with antiplatelet or anticoagulant agents. [9] [10] [11] However, stroke rates as high as 20% per year have been reported in patients who receive nonoperative management. 7 Our results indicate that in selected patients internal CEA for treatment of acute and subacute symptomatic ICA occlusion is feasible and associated with limited morbidity, including ipsilateral and contralateral stroke, and mortality. When internal CEA is not feasible because of extensive chronic occlusion, external CEA can be performed to increase collateral cerebral perfusion, with limited morbidity and mortality.
The pathophysiology of stroke after ICA occlusion depends not only on cerebral hypoperfusion but also on distal embolization. Emboli can originate from a diseased external carotid artery or common carotid artery, the proximal stump of an occluded ICA, and the distal end of an occluded ICA. Medical treatment with anti-platelet and anticoagulant therapy might help reduce propagation of thromboemboli. However, without surgical revascularization, persistent cerebral hypoperfusion and atherosclerotic plaques can lead to increased risk for recurrent stroke. CEA not only increases perfusion to ipsilateral and contralateral cerebral hemispheres, but also eliminates a source of embolization. 15, 16 After ICA occlusion, reduced cerebral blood flow has been reported by several investigators based on measurements of cerebral blood flow by stable xenon CT techniques. [17] [18] [19] Our algorithm for management of patients with symptoms of TIA, amaurosis fugax, and stroke includes evaluation with head CT and carotid duplex US scanning. In cases of ipsilateral ICA occlusion a four-vessel carotid-cerebral arteriogram is obtained to confirm the diagnosis. In the absence of hemorrhagic cerebral infarct and overt signs of major stroke and obtundation (Rankin class 4), ipsilateral carotid artery exploration is performed with attempted ICA thromboendarterectomy. In the absence of backbleeding from the distal ICA, catheter-directed sequential thrombectomy is performed in 2 cm increments with a No. 2 Fogarty catheter, and is limited to the proximal 10 cm of the ICA. In cases of chronic occlusion or extensive disease prohibiting ICA thromboendarterectomy, the ICA is suture ligated and external CEA is performed. Only one patient had stroke after internal CEA. A review of preoperative head CT scans indicated the presence of a small hemorrhagic infarct that was missed before CEA. Earlier recognition of the hemorrhagic infarct might have resulted in better patient selection for CEA and prevented stroke in this patient. Our routine treatment of hemorrhagic stroke is conservative and nonsurgical. Rob 10 analyzed the results of carotid revascularization to treat ICA occlusion and indicated hemorrhagic infarct to be the leading cause of death. Our experience suggests that after careful selection of patients, 34% with acute or subacute ICA occlusion are amenable to internal CEA, with limited morbidity and mortality. Furthermore, external CEA can be accomplished in patients not amenable to internal CEA (66%), with similar perioperative morbidity and mortality. Stroke-free survival for patients undergoing internal CEA (91% at 3 years and 71% at 5 years) was improved compared with that in patients not amenable to internal CEA and requiring external CEA only (85% at 3 years and 60% at 5 years). These differences were not, however, statistically significant.
The feasibility, safety, and improved outcomes of CEA for ICA occlusion have been supported by several other investigators as well. Welling et al 20 reviewed their data for 24 patients undergoing carotid revascularization to treat symptomatic ICA occlusion and reported a 63% technical success rate and 0% mortality. Surgery in these patients was performed up to 3 weeks after onset of clinical symptoms. In a more recent report from the same center, Kasper et al 12 reported the outcome for CEA to treat ICA occlusion within 8 days of clinical presentation. In their group of 29 patients, successful restoration of ICA flow was possible in 83%, with 3% mortality. 12 Improvement in results in this later series was attributed to better patient selection. In comparison with this last report, we found in the present study that restoration of ICA flow was possible in only one third of patients. This is no doubt a result of patient selection, because all patients received treatment within 2 weeks from onset of symptoms. Demographics may also have a part, inasmuch as there was a predominance of diabetes and smoking in patients in whom ICA flow could not be reestablished.
The emphasis of the previously mentioned series dealing with recent ICA occlusion was only to reestablish flow to the ICA. Over the long term this reduces risk for stroke. 12 In the present study, we found that treatment of external carotid disease when flow cannot be restored to the ICA may also increase stroke-free survival, as compared with natural history data of up to 20% per year risk of recurrent stroke after nonoperative management of ICA occlusion. 7 In selected patients with recent symptomatic ICA occlusion, internal and external CEA is technically feasible, with acceptable morbidity and mortality, and improved 5-year stroke-free survival. Careful patient selection on the basis of neurologic examination and head CT is crucial in limiting the irreversible complications of hemorrhagic stroke and death that have been previously reported. A randomized prospective trial is needed to define the true natural history of symptomatic ICA occlusion and the potential benefits of carotid revascularization.
